Dr Mark Ashford
Role at ANSTO
Mark’s work primarily revolves around the Radiometals theme in LifeSciences. He also manages and co-ordinates activities involved in maintaining ANSTO LifeSciences’ ISO9001 and ISO14001 accreditation.
Originally a Chemistry Demonstrator and Tutor at the University of Wollongong, Mark joined ANSTO LifeSciences as a QA/QC officer in 2009. This led to his current position as an Organic Chemist and Quality Documentation Officer in 2010.
Research interests and areas of expertise
Mark’s research interests lie in SPECT and PET radiochemistry and organic/inorganic chemistry. He has expertise in PET and SPECT radiochemistry (including radiolabelling known and novel compounds and small peptides/proteins with I-123, I-125, F-18, C-11 and Ga-68), HPLC separation techniques, organic chemistry and Quality/Environmental Management Systems.
Qualifications & Achievements
- 2010 PhD from the University of Wollongong,
- 2005 B. Med. Chem. Honours Adv. (Class 1) from the University of Wollongong
- Dean's merit list 2005
Roberts, M. P., Nguyen, V., Ashford, M. E., Berghofer, P., Wyatt, N. A., Krause-Heuer, A. M., Pham, T. Q., Taylor, S. R., Hogan, L., Jiang, C. D., Fraser, B. H., Lengkeek, N. A., Matesic, L., Gregoire, M. C., Denoyer, D., Hicks, R. J and Greguric, I. Synthesis and in vivo evaluation of [123I]melanin-targeted agents. Journal of Medicinal Chemistry, 58(15), 6214-6224 (2015). doi: 10.1021/acs.jmedchem.5b00777
Ashford, M., Ngyuyen, V. H., Greguric, I., Pham, T., Keller, P., Katsifis, A. Synthesis and in vitro evaluation of tetrahydroisoquinolines with pendent aromatics as sigma-2 (σ2) selective ligands. Organic & Biomolecular Chemistry, 12, 783-794 (2014). doi: 10.1039/C3OB42254B